Lung, Phase II

The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung Cancer

Volunteers
Health Professionals

What is the purpose of this trial?

This is a phase 2 study to investigate NC318 alone or in combination with Pembrolizumab in patients with advanced non-small cell lung cancer.

Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Scott Gettinger

scott.gettinger@yale.edu

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Scott Gettinger, MD
Professor of Internal Medicine (Medical Oncology); Chief, Thoracic Medical Oncology

Sub-Investigators

Last Updated
09/16/2024
Study HIC
#2000028206